A federal judge allowed the abortion pill mifepristone to continue being distributed by mail nationwide for now, but warned the Biden-era policy could soon face major legal changes as a Food and Drug Administration (FDA) safety review of the drug unfolds.The legal challenge to the U.S. Food and Drug Administration's January 2023 Risk Evaluation and Mitigation Strategy (REMS) seeks to end the "certified pharmacies" regulation that allows for the drug to be mailed across state lines while the federal agency continues its review.U.S. District Court Judge David C. Joseph, appointed by President Do...
HALO NEWSLETTER
Join HALO today and unlock this story instantly — It's Free